top of page

Congressional Support for the Lymphedema Treatment Act

Congressional Support for the Lymphedema Treatment Act

The U.S. Congress and federal government agencies are reevaluating how the Centers for Medicare and Medicaid Services reviews reimbursement payments for lymphedema treatment and evolving the system to better serve more survivors. The Lymphedema Treatment Act is a bipartisan and bicameral federal bill, and the Oncology Nursing Society joins coalition advocates in promoting it. Patient-centered care enhances quality outcomes. As the most trusted profession, nurses are often the first healthcare providers to engage with patients and provide critical symptom management education. Join ONS, nurses, members of Congress, and policy experts to discuss the impact and future of patient-centered lymphedema care through coverage and reimbursement.

Virtual Webinar Monday, October 24, 3–4 pm ET

Speakers Include:

· U.S. Representative Earl L. “Buddy” Carter (R-GA) · U.S. Representative Jan Schakowsky (D-IL) · U.S. Senator Maria Cantwell (D-WA) · U.S. Senator Chuck Grassley (R-IA) · Heather Ferguson, Executive Director, Lymphedema Treatment Advocacy Group · Alec Stone, MA, MPA, Government Affairs Director, ONS · Kerri Stuart, RN, MSN, OCN®, Director Cancer Services, Sutter Roseville Medical Center

We hope you will join us, Alec Stone, MA, MPA Government Affairs Director

28 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page